GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive Officer, will present at the Canaccord Genuity Medical
Technologies & Diagnostics Form to be held in New York, NY at the Westin Grand Central Hotel on Thursday, November 17, 2016 at
1:30 p.m. Eastern Time. The presentation will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is designed to support a broad range of
molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor
detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex®. For more information, visit
www.genmarkdx.com.
GenMark Diagnostics, Inc.
Hany Massarany, 760-448-4325
President, Chief Executive Officer
View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006967/en/